BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26225839)

  • 1. Integrated genomic analyses identify KDM1A's role in cell proliferation via modulating E2F signaling activity and associate with poor clinical outcome in oral cancer.
    Narayanan SP; Singh S; Gupta A; Yadav S; Singh SR; Shukla S
    Cancer Lett; 2015 Oct; 367(2):162-72. PubMed ID: 26225839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
    Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
    Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
    Hayami S; Yoshimatsu M; Veerakumarasivam A; Unoki M; Iwai Y; Tsunoda T; Field HI; Kelly JD; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
    Mol Cancer; 2010 Mar; 9():59. PubMed ID: 20226085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
    Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
    He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
    Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.
    Li X; Zhang K; Hu Y; Luo N
    Am J Pathol; 2023 Apr; 193(4):442-455. PubMed ID: 36681189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma.
    Huang M; Chen C; Geng J; Han D; Wang T; Xie T; Wang L; Wang Y; Wang C; Lei Z; Chu X
    Cancer Lett; 2017 Jul; 398():12-21. PubMed ID: 28377178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
    Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
    Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.
    Pishas KI; Drenberg CD; Taslim C; Theisen ER; Johnson KM; Saund RS; Pop IL; Crompton BD; Lawlor ER; Tirode F; Mora J; Delattre O; Beckerle MC; Callen DF; Sharma S; Lessnick SL
    Mol Cancer Ther; 2018 Sep; 17(9):1902-1916. PubMed ID: 29997151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-329 inhibits cell proliferation and tumor growth while facilitates apoptosis via negative regulation of KDM1A in gastric cancer.
    Cai L; Chen Q; Fang S; Lian M; Cai M
    J Cell Biochem; 2018 Apr; 119(4):3338-3351. PubMed ID: 29130516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
    Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
    Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway.
    Zhang W; Ruan X; Li Y; Zhi J; Hu L; Hou X; Shi X; Wang X; Wang J; Ma W; Gu P; Zheng X; Gao M
    Theranostics; 2022; 12(4):1500-1517. PubMed ID: 35198054
    [No Abstract]   [Full Text] [Related]  

  • 17. Kdm1a promotes SCLC progression by transcriptionally silencing the tumor suppressor Rest.
    Jin Y; Ma D; Gramyk T; Guo C; Fang R; Ji H; Shi YG
    Biochem Biophys Res Commun; 2019 Jul; 515(1):214-221. PubMed ID: 31146914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.
    Yang H; Li Q; Zhao W; Yuan D; Zhao H; Zhou Y
    FEBS Lett; 2014 Jan; 588(1):192-7. PubMed ID: 24316513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.
    Pajtler KW; Weingarten C; Thor T; Künkele A; Heukamp LC; Büttner R; Suzuki T; Miyata N; Grotzer M; Rieb A; Sprüssel A; Eggert A; Schramm A; Schulte JH
    Acta Neuropathol Commun; 2013 May; 1():19. PubMed ID: 24252778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Deacetylation Regulated by KDM1A to Suppress DACT1 in Proliferation and Migration of Cervical Cancer.
    Zeng L; Chen C; Yao C
    Anal Cell Pathol (Amst); 2021; 2021():5555452. PubMed ID: 34350095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.